PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Liothyronine sodium - Treatment resistant depression

PAD Profile : Liothyronine sodium - Treatment resistant depression Important

Keywords :
TRD, L-T3, L-Tri-iodothyronine sodium, low value medicines, drugs of low clinical value, LVM, drugs of limited clinical value
Important Information :
Consultant psychiatrists only.

Traffic Light Status

Status 1 of 1.

Status :
Red
Formulations :
  • Capsules
  • Tablets
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
R
Un
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

No indications returned.

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
01 November 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee agreed  that the decision made by APC in March 2016 still stands and a RED traffic light status for Liothyronine (T3) as an option for treatment resistant depression in a niche group of adults whose depression has failed to respond to several antidepressants and is intolerant to lithium augmentation.

Where liothyronine is prescribed for the treatment of depression only, this should be under the care of an NHS consultant psychiatrist.

The most cost-effective formulation should be prescribed at initiation.

Associated BNF Codes

06. Endocrine System
06.02.01. Thyroid hormones
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More